Author Question: Recent evaluations of the Head Start program have indicated that the a. program has little or no ... (Read 169 times)

CQXA

  • Hero Member
  • *****
  • Posts: 546
Recent evaluations of the Head Start program have indicated that the
 
  a. program has little or no effect on children's performance in school.
  b. beneficial effects of the program do not appear until the third or fourth year of elementary school.
  c. program has resulted in long-lasting improvements in intellectual performance.
  d. program has yielded short-term benefits in improving children's performance in school.

Question 2

Which of the following is not a disadvantage of longitudinal studies?
 
  a. Participants may get better at taking the tests over time.
  b. There is the possibility of an age-history confound.
  c. There is the possibility of a cohort effect.
  d. They can be rather costly.



sokh

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library